Iradimed Corp. (NASDAQ: IRMD) reported Q4 EPS of $0.11, $0.07 better than the analyst estimate of $0.04. Revenue for the quarter came in at $6 million versus the consensus estimate of $6.09 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.